Acarix Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Per Persson, was filed 17 Jan 2020.
Acarix: what insiders have been doing
Acarix is a listed company. Filings by its managers are published through Finansinspektionen. Acarix has had no insider filing for more than a year; the last one goes back to 17 January 2020.
Since 2019, the database holds 3 purchases and no sales by insiders of the company.
Elsewhere in the same market, our signals recently picked up insider purchases at Dynavox Group AB and Rusta AB (publ). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- +22.3%Entry 0.87 · Close at T+365 1.06
- +17.0%Entry 0.88 · Close at T+365 1.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
· cache
- 12,500 shares@ SEK 1.2927.3% of flowAktieFI:csv-53a3790ac9680607b109Canonical exit: 16 Apr 2020 (T+90)
- 9,954 shares@ SEK 1.35100.0% of flowAktieISIN SE0009268717FI:csv-1f06c4d074f52ac785b8Canonical exit: 9 Apr 2020 (T+90)
- 29,100 shares@ SEK 1.5072.7% of flowAktieFI:csv-c7f756bef389c512c767Canonical exit: 23 Jan 2020 (T+90)
3 of 3 declarations
About Acarix
Acarix is a company focused on developing diagnostic solutions for cardiovascular diseases. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations